Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mercia Pharma Inc.
DescriptionMAS-1 adjuvant combined with standard seasonal TIV (trivalent inactivated influenza vaccine)
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationInfluenza virus
Indication DetailsPrevent seasonal flu
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today